Canadian patients with the autoimmune liver disease primary biliary cholangitis (PBC) saw the first approval of a new drug for…
Magdalena Kegel, PhD
Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel, PhD
Nonalcoholic steatohepatitis, or NASH, might be prevented by treatments able to target certain immune cells, according to a recent study in mice…
Cerenis Therapeutics has initiated a Phase 1 clinical trial of CER-209 for the treatment of non-alcoholic steatohepatitis (NASH) and…
A diet too low in protein causes the liver to shrink extensively and become less efficient in doing its work.
A compound found in broccoli sprouts apparently prevents obesity and fatty liver disease by boosting the amount of brown fat and improving…
Researchers show that the effects of a single high-fat meal alters the sensitivity to insulin and changes liver metabolism in…